JP2005519035A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005519035A5 JP2005519035A5 JP2003548857A JP2003548857A JP2005519035A5 JP 2005519035 A5 JP2005519035 A5 JP 2005519035A5 JP 2003548857 A JP2003548857 A JP 2003548857A JP 2003548857 A JP2003548857 A JP 2003548857A JP 2005519035 A5 JP2005519035 A5 JP 2005519035A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- mouse
- spots
- peptide
- dose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT19242001 | 2001-12-07 | ||
| PCT/EP2002/013791 WO2003047602A1 (en) | 2001-12-07 | 2002-12-05 | Immunostimulatory oligodeoxynucleotides |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005519035A JP2005519035A (ja) | 2005-06-30 |
| JP2005519035A5 true JP2005519035A5 (cg-RX-API-DMAC10.html) | 2006-01-26 |
Family
ID=3689335
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003548857A Withdrawn JP2005519035A (ja) | 2001-12-07 | 2002-12-05 | 免疫促進性オリゴデオキシヌクレオチド |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20050250716A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP1450821A1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2005519035A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2002358616A1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA2452909A1 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2003047602A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001022972A2 (en) * | 1999-09-25 | 2001-04-05 | University Of Iowa Research Foundation | Immunostimulatory nucleic acids |
| EP1390494A2 (en) | 2001-05-21 | 2004-02-25 | Intercell AG | Method for stabilising of nucleic acids |
| JP2005533855A (ja) | 2002-07-24 | 2005-11-10 | インターツェル・アクチェンゲゼルシャフト | 病原性ウイルスからの別のリーディングフレームによりコードされる抗原 |
| EP1537418A2 (en) | 2002-09-13 | 2005-06-08 | Intercell AG | Method for isolating hepatitis c virus peptides |
| AU2004224746B2 (en) | 2003-03-24 | 2009-04-23 | Valneva Austria Gmbh | Improved vaccines |
| US7635487B2 (en) | 2003-04-15 | 2009-12-22 | Intercell Ag | S. pneumoniae antigens |
| CA2530062A1 (en) * | 2003-07-11 | 2005-01-20 | Intercell Ag | Hcv vaccines |
| AU2004263037B2 (en) * | 2003-08-11 | 2011-02-10 | Japan As Represented By The Director-General Of National Institute Of Infectious Diseases | Novel vaccine containing adjuvant capable of inducing mucosal immunity |
| JP4817599B2 (ja) * | 2003-12-25 | 2011-11-16 | 独立行政法人科学技術振興機構 | 免疫活性増強剤とこれを用いた免疫活性の増強方法 |
| JP2008507537A (ja) * | 2004-07-23 | 2008-03-13 | アドバイシーズ,インコーポレイテッド | 予防接種レスポンスを増強する成長ホルモン放出ホルモン |
| WO2007062107A2 (en) | 2005-11-25 | 2007-05-31 | Coley Pharmaceutical Gmbh | Immunostimulatory oligoribonucleotides |
| EP2292647A3 (en) | 2006-07-07 | 2011-06-08 | Intercell AG | Small Streptococcus pyogenes antigens and their use |
| EP2289906A1 (en) | 2006-09-15 | 2011-03-02 | Intercell AG | Borrelia antigens |
| EP1923069A1 (en) | 2006-11-20 | 2008-05-21 | Intercell AG | Peptides protective against S. pneumoniae and compositions, methods and uses relating thereto |
| EP2266592A3 (en) | 2007-01-12 | 2012-08-08 | Intercell AG | Protective proteins of S. agalactiae, combinations thereof and methods of using the same |
| CA2685805A1 (en) | 2007-05-02 | 2008-11-13 | Intercell Ag | Klebsiella antigens |
| EP2511291A3 (en) | 2007-06-18 | 2012-11-07 | Intercell AG | Chlamydia antigens |
| AU2009226949A1 (en) | 2008-03-17 | 2009-09-24 | Intercell Ag | Peptides protective against S. pneumoniae and compositions, methods and uses relating thereto |
| ES2569907T3 (es) | 2008-06-27 | 2016-05-13 | Zoetis Services Llc | Composiciones adyuvantes novedosas |
| EP2424882A2 (en) | 2009-02-05 | 2012-03-07 | Intercell AG | Peptides protective against e. faecalis, methods and uses relating thereto |
| EP2405938A2 (en) | 2009-02-13 | 2012-01-18 | Intercell AG | Nontypable haemophilus influenzae antigens |
| US8454547B2 (en) | 2009-02-25 | 2013-06-04 | The Invention Science Fund I, Llc | Device, system, and method for controllably reducing inflammatory mediators in a subject |
| WO2011031139A1 (en) | 2009-09-09 | 2011-03-17 | Universiteit Utrecht Holding B.V. | An ataq protein or a part thereof as a vaccine |
| SA110310855B1 (ar) | 2009-11-13 | 2014-09-16 | Laboratories Leti S L Unipersonal | استخدام مصدر l3 و/ أو l5 كلقاح أو كوسيلة تشخيصية لمرض طفيلي |
| KR101907434B1 (ko) | 2010-09-03 | 2018-10-12 | 발네바 오스트리아 게엠베하 | C. 디피실의 a 독소 및 b 독소 단백질의 분리된 폴리펩타이드 및 이의 용도 |
| US9187751B2 (en) | 2010-11-10 | 2015-11-17 | Laboratorios Leti, S.L. | Adjuvant |
| DE102011018499A1 (de) | 2011-04-23 | 2012-10-25 | Emc Microcollections Gmbh | Topische Nanopartikel-Vakzine zur Immunstimulation der dendritischen Zellen in der Haut |
| PT2941233T (pt) * | 2013-01-07 | 2020-11-13 | Univ Pennsylvania | Composições e métodos para tratar linfoma cutâneo de células t |
| KR20200039025A (ko) | 2013-09-19 | 2020-04-14 | 조에티스 서비시즈 엘엘씨 | 유성 아쥬반트 |
| MX391930B (es) | 2015-01-16 | 2025-03-21 | Zoetis Services Llc | Vacuna contra la fiebre aftosa. |
| WO2017046409A1 (en) | 2015-09-18 | 2017-03-23 | Rijksuniversiteit Groningen | Long chain inulin for stimulating an immune response |
| KR20220010478A (ko) | 2019-05-20 | 2022-01-25 | 발네바 에스이 | 기도 감염의 치료 또는 예방용 서브유닛 백신 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3725545A (en) * | 1971-02-03 | 1973-04-03 | R Maes | Enhancement of antibody production by nucleic acid-polycation complexes |
| US3906092A (en) * | 1971-11-26 | 1975-09-16 | Merck & Co Inc | Stimulation of antibody response |
| DK0610396T3 (da) * | 1991-10-23 | 2001-01-29 | Baylor College Medicine | Fingeraftryksidentifikation af bakteriestammer med anvendelse af repetitiv DNA-sekvensamplifikation |
| AU713040B2 (en) * | 1994-07-15 | 1999-11-18 | University Of Iowa Research Foundation, The | Immunomodulatory oligonucleotides |
| US6207646B1 (en) * | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
| FI970588A7 (fi) * | 1994-08-12 | 1997-04-11 | Wellstat Therapeutics Corp | Menetelmät verenmyrkytyksen tai tulehdussairauksien hoitamiseksi oksipuriininukleosideillä |
| CO4600681A1 (es) * | 1996-02-24 | 1998-05-08 | Boehringer Ingelheim Pharma | Composicion farmaceutica para la modulacion inmunitaria |
| US6589940B1 (en) * | 1997-06-06 | 2003-07-08 | Dynavax Technologies Corporation | Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof |
| DE19803453A1 (de) * | 1998-01-30 | 1999-08-12 | Boehringer Ingelheim Int | Vakzine |
| EP1272215B1 (en) * | 2000-04-14 | 2007-10-10 | Intercell AG | Pharmaceutical preparations comprising modified peptides |
| HU228264B1 (en) * | 2000-06-08 | 2013-02-28 | Intercell Ag | Immunostimulatory oligodeoxynucleotides |
| AT410173B (de) * | 2000-06-08 | 2003-02-25 | Cistem Biotechnologies Gmbh | Antigene zusammensetzung |
| EP1347775B1 (en) * | 2001-01-05 | 2016-11-30 | Valneva Austria GmbH | Uses for polycationic compounds as vaccine adjuvants |
| EP1390494A2 (en) * | 2001-05-21 | 2004-02-25 | Intercell AG | Method for stabilising of nucleic acids |
| US7276489B2 (en) * | 2002-10-24 | 2007-10-02 | Idera Pharmaceuticals, Inc. | Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends |
| CA2388049A1 (en) * | 2002-05-30 | 2003-11-30 | Immunotech S.A. | Immunostimulatory oligonucleotides and uses thereof |
| AU2004224746B2 (en) * | 2003-03-24 | 2009-04-23 | Valneva Austria Gmbh | Improved vaccines |
| ES2351489T3 (es) * | 2003-03-24 | 2011-02-07 | Intercell Ag | Vacunas mejoradas. |
-
2002
- 2002-12-05 US US10/497,591 patent/US20050250716A1/en not_active Abandoned
- 2002-12-05 JP JP2003548857A patent/JP2005519035A/ja not_active Withdrawn
- 2002-12-05 CA CA002452909A patent/CA2452909A1/en not_active Abandoned
- 2002-12-05 EP EP02792903A patent/EP1450821A1/en not_active Ceased
- 2002-12-05 AU AU2002358616A patent/AU2002358616A1/en not_active Abandoned
- 2002-12-05 WO PCT/EP2002/013791 patent/WO2003047602A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2003535146A5 (cg-RX-API-DMAC10.html) | ||
| US6140482A (en) | Primary phosphoramidate internucleoside linkages and oligonucleotides containing the same | |
| US7115579B2 (en) | Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosides | |
| EP1390495B1 (en) | Immunostimulatory oligodeoxynucleic molecules | |
| DE60100814T2 (de) | Immunstimulierende oligodeoxynukleotide | |
| ES2543207T3 (es) | Métodos y composiciones para la inhibición de respuestas inmunes innatas y autoinmunidad | |
| US5672697A (en) | Nucleoside 5'-methylene phosphonates | |
| US7709449B2 (en) | Nucleic acid-based compounds and methods of use thereof | |
| EP1286695B1 (en) | Antigenic composition comprising a polycationic peptide and inosine and cytosine | |
| EP2361980B1 (en) | Methods and compositions for inhibition of immune responses and autoimmunity | |
| US7105495B2 (en) | Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosides | |
| US20110040082A1 (en) | Modifications of antimetabolite gemcitabine for incorporation in CpG oligonucleotides | |
| US20030212029A1 (en) | Modulation of oligonucleotides CpG-mediated immune stimulation by positional modification of nucleosides | |
| JP2010148524A (ja) | 5’cpg核酸およびその使用方法 | |
| JP2002531053A5 (cg-RX-API-DMAC10.html) | ||
| JP6106280B2 (ja) | 阻害性オリゴヌクレオチド及びその使用 | |
| Kozlov et al. | Nonenzymatic oligomerization reactions on templates containing inosinic acid or diaminopurine nucleotide residues | |
| US6531589B1 (en) | Base protecting groups and synthons for oligonucleotide synthesis | |
| An et al. | Synthesis of novel 3′-methylene H-phosphonate thymidines | |
| Zatsepin et al. | Synthesis of (2′ S)‐and (2′ R)‐2′‐Deoxy‐2′‐[(2‐methoxyethoxy) amino] Pyrimidine Nucleosides and Oligonucleotides | |
| WO2004060323A2 (en) | Novel inhibitors of poxvirus replication |